Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994625148> ?p ?o ?g. }
- W1994625148 endingPage "576" @default.
- W1994625148 startingPage "568" @default.
- W1994625148 abstract "Although the essentiality of dietary Se for sheep has been known for decades, the chemical source and Se dosage for optimal health remain unclear. In the United States, the Food and Drug Administration (FDA) regulates Se supplementation, regardless of the source of Se, at 0.3 mg of Se/kg of diet (as fed), which is equivalent to 0.7 mg of Se/d or 4.9 mg of Se/wk per sheep. The objectives of this study were to evaluate the effects of Se source (inorganic vs. organic) and supplementation rate (FDA vs. supranutritional rates of 14.7 and 24.5 mg of Se/wk) on whole-blood (WB) and serum-Se concentrations. Mature ewes (n = 240) were randomly assigned to 8 treatment groups (n = 30 each) based on Se supplementation rate (4.9, 14.7, and 24.5 mg of Se∙wk−1∙sheep−1) and source [Na-selenite, Na-selenate (4.9 mg/wk only), and organic Se-yeast] with a no-Se control group (0 mg of Se/wk). Treatment groups were balanced for healthy and footrot-affected ewes. For 1 yr, ewes were individually dosed once weekly with 0, 4.9, 14.7, or 24.5 mg of Se, quantities equivalent to their summed daily supplementation rates. Serum- and WB-Se concentrations were measured every 3 mo in all ewes; additionally, WB-Se concentrations were measured once monthly in one-half of the ewes receiving 0 or 4.9 mg of Se/wk. Ewes receiving no Se showed a 78.8 and 58.8% decrease (P < 0.001) in WB- (250 to 53 ng/mL) and serum- (97 to 40 ng/mL) Se concentrations, respectively, over the duration of the study. Whole-blood Se decreased primarily during pregnancy (−57%; 258 to 111 ng/mL) and again during peak lactation (−44%; 109 to 61 ng/mL; P < 0.001). At 4.9 mg of Se/wk, Se-yeast (364 ng/mL, final Se concentration) was more effective than Na-selenite (269 ng/mL) at increasing WB-Se concentrations (P < 0.001). Supranutritional Se-yeast dosages increased WB-Se concentrations in a dose-dependent manner (563 ng/mL, 14.7 mg of Se/wk; 748 ng/mL, 24.5 mg of Se/wk; P < 0.001), whereas WB-Se concentrations were not different for the Na-selenite groups (350 ng/mL, 14.7 mg of Se/wk; 363 ng/mL, 24.5 mg of Se/wk) or the 4.9 mg of Se/wk Se-yeast group (364 ng/mL). In summary, the dose range whereby Se supplementation increased blood Se concentrations was more limited for inorganic Na-selenite than for organic Se-yeast. The smallest rate (FDA-recommended quantity) of organic Se supplementation was equally effective as supranutritional rates of Na-selenite supplementation in increasing WB-Se concentrations, demonstrating the greater oral bioavailability of organic Se." @default.
- W1994625148 created "2016-06-24" @default.
- W1994625148 creator A5015408305 @default.
- W1994625148 creator A5023572003 @default.
- W1994625148 creator A5034720305 @default.
- W1994625148 creator A5039537734 @default.
- W1994625148 creator A5043086031 @default.
- W1994625148 creator A5046197645 @default.
- W1994625148 creator A5047777876 @default.
- W1994625148 creator A5059666699 @default.
- W1994625148 creator A5065958967 @default.
- W1994625148 date "2012-02-01" @default.
- W1994625148 modified "2023-10-02" @default.
- W1994625148 title "Organic and inorganic selenium: I. Oral bioavailability in ewes1" @default.
- W1994625148 cites W1007535606 @default.
- W1994625148 cites W144180324 @default.
- W1994625148 cites W1966695628 @default.
- W1994625148 cites W1968327544 @default.
- W1994625148 cites W1970739279 @default.
- W1994625148 cites W1984093159 @default.
- W1994625148 cites W1986370482 @default.
- W1994625148 cites W2006053725 @default.
- W1994625148 cites W2006125255 @default.
- W1994625148 cites W2015118051 @default.
- W1994625148 cites W2022773683 @default.
- W1994625148 cites W2023823250 @default.
- W1994625148 cites W2026086416 @default.
- W1994625148 cites W2035272262 @default.
- W1994625148 cites W2036019166 @default.
- W1994625148 cites W2050183208 @default.
- W1994625148 cites W2052424347 @default.
- W1994625148 cites W2056201418 @default.
- W1994625148 cites W2059673879 @default.
- W1994625148 cites W2070742508 @default.
- W1994625148 cites W2104852596 @default.
- W1994625148 cites W2128800145 @default.
- W1994625148 cites W2140455544 @default.
- W1994625148 cites W2142296427 @default.
- W1994625148 cites W2306460341 @default.
- W1994625148 cites W2398012834 @default.
- W1994625148 cites W2413587365 @default.
- W1994625148 cites W79180642 @default.
- W1994625148 doi "https://doi.org/10.2527/jas.2011-4075" @default.
- W1994625148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21965451" @default.
- W1994625148 hasPublicationYear "2012" @default.
- W1994625148 type Work @default.
- W1994625148 sameAs 1994625148 @default.
- W1994625148 citedByCount "51" @default.
- W1994625148 countsByYear W19946251482012 @default.
- W1994625148 countsByYear W19946251482013 @default.
- W1994625148 countsByYear W19946251482014 @default.
- W1994625148 countsByYear W19946251482015 @default.
- W1994625148 countsByYear W19946251482016 @default.
- W1994625148 countsByYear W19946251482017 @default.
- W1994625148 countsByYear W19946251482018 @default.
- W1994625148 countsByYear W19946251482019 @default.
- W1994625148 countsByYear W19946251482020 @default.
- W1994625148 countsByYear W19946251482021 @default.
- W1994625148 countsByYear W19946251482022 @default.
- W1994625148 countsByYear W19946251482023 @default.
- W1994625148 crossrefType "journal-article" @default.
- W1994625148 hasAuthorship W1994625148A5015408305 @default.
- W1994625148 hasAuthorship W1994625148A5023572003 @default.
- W1994625148 hasAuthorship W1994625148A5034720305 @default.
- W1994625148 hasAuthorship W1994625148A5039537734 @default.
- W1994625148 hasAuthorship W1994625148A5043086031 @default.
- W1994625148 hasAuthorship W1994625148A5046197645 @default.
- W1994625148 hasAuthorship W1994625148A5047777876 @default.
- W1994625148 hasAuthorship W1994625148A5059666699 @default.
- W1994625148 hasAuthorship W1994625148A5065958967 @default.
- W1994625148 hasConcept C126322002 @default.
- W1994625148 hasConcept C140793950 @default.
- W1994625148 hasConcept C178790620 @default.
- W1994625148 hasConcept C181389837 @default.
- W1994625148 hasConcept C185592680 @default.
- W1994625148 hasConcept C2780347965 @default.
- W1994625148 hasConcept C553756173 @default.
- W1994625148 hasConcept C71924100 @default.
- W1994625148 hasConcept C86803240 @default.
- W1994625148 hasConcept C98274493 @default.
- W1994625148 hasConceptScore W1994625148C126322002 @default.
- W1994625148 hasConceptScore W1994625148C140793950 @default.
- W1994625148 hasConceptScore W1994625148C178790620 @default.
- W1994625148 hasConceptScore W1994625148C181389837 @default.
- W1994625148 hasConceptScore W1994625148C185592680 @default.
- W1994625148 hasConceptScore W1994625148C2780347965 @default.
- W1994625148 hasConceptScore W1994625148C553756173 @default.
- W1994625148 hasConceptScore W1994625148C71924100 @default.
- W1994625148 hasConceptScore W1994625148C86803240 @default.
- W1994625148 hasConceptScore W1994625148C98274493 @default.
- W1994625148 hasIssue "2" @default.
- W1994625148 hasLocation W19946251481 @default.
- W1994625148 hasLocation W19946251482 @default.
- W1994625148 hasOpenAccess W1994625148 @default.
- W1994625148 hasPrimaryLocation W19946251481 @default.
- W1994625148 hasRelatedWork W1974263738 @default.
- W1994625148 hasRelatedWork W1985495801 @default.
- W1994625148 hasRelatedWork W2046807749 @default.